akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 130 blog entries.

Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd

MHRA Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd Drug alert number: EL(25)A/39 Date issued: 07 August 2025 Zydus Pharmaceuticals UK LTD has informed the MHRA that there is an error on the artwork for the outer carton and Patient Information Leaflet (PIL) of Topiramate Zydus Pharmaceuticals UK [...]

The post Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd appeared first on Community Pharmacy England.

By |August 7th, 2025|Lexpos News|Comments Off on Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd

10 products re-classified as special containers from August 2025

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 August 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Hydrocortisone 500microgram granules in capsules for opening Alkindi® 0.5 mg granules in capsules [...]

The post 10 products re-classified as special containers from August 2025 appeared first on Community Pharmacy England.

By |August 1st, 2025|Lexpos News|Comments Off on 10 products re-classified as special containers from August 2025

National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment

National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment National Patient Safety Alert Reference Number: NatPSA/2025/004/MVA Date issued: 29 July 2025 Explanation of identified issue: The following antimicrobial medicines used to treat tuberculosis (TB) will be intermittently available until at least the end of 2025: Rifampicin 150mg and 300mg capsules Rifampicin [...]

The post National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment appeared first on Community Pharmacy England.

By |July 29th, 2025|Lexpos News|Comments Off on National Patient Safety Alert: Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment

MHRA Class 2 Medicines Recall: Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation, suspension (CD Pharma Ltd)

MHRA Class 2 Medicines Recall: Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation, suspension (CD Pharma Ltd) Drug alert number: EL(25)A/35 Date issued: 24 July 2025 CD Pharma Ltd have notified the MHRA of an error on the outer carton of the product for the batches listed in this notification. While the total [...]

The post MHRA Class 2 Medicines Recall: Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation, suspension (CD Pharma Ltd) appeared first on Community Pharmacy England.

By |July 24th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation, suspension (CD Pharma Ltd)

Retrospective reimbursement prices for April 2025

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the April 2025 reimbursement prices for the following products, to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed to grant [...]

The post Retrospective reimbursement prices for April 2025 appeared first on Community Pharmacy England.

By |July 8th, 2025|Lexpos News|Comments Off on Retrospective reimbursement prices for April 2025